Douglas Carr - 25 Jan 2022 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
VP of Finance and Operations
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
25 Jan 2022
Net transactions value
$0
Form type
4
Filing time
27 Jan 2022, 15:49:23 UTC
Previous filing
17 Jun 2021
Next filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 25 Jan 2022 Common Stock 35,000 $13.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.